Earnings Feed
Sign Up
Home/Insiders/WIDDER KENNETH J
WK
SEC Insider//CIK 0001065168

WIDDER KENNETH J

CIK 00010651685 companiesSAN DIEGO, CA
SEC Profile

Transactions

50

Companies

5

Filings

10

CIK

0001065168

Recent Transactions

50 trades
  • Disposition to Issuer
    Evoke Pharma Inc$EVOK

    Stock Option (Right to Buy)

    2025-12-17−1,187→ 0 total
  • Disposition to Issuer
    Evoke Pharma Inc$EVOK

    Stock Option (Right to Buy)

    2025-12-17−5,833→ 0 total
  • Sale
    QuidelOrtho Corp$QDEL

    Common Stock

    2025-11-25$27.81/sh−4,026→ 37,061 total
  • Exercise/Conversion
    QuidelOrtho Corp$QDEL

    Common Stock

    2025-11-25$15.74/sh+7,021→ 41,087 total
  • Exercise/Conversion
    QuidelOrtho Corp$QDEL

    Non-Qualified Stock Options

    2025-11-25−7,021→ 0 total
  • Award
    QuidelOrtho Corp$QDEL

    Restricted Stock Units (Converted)

    2025-05-29+2,926→ 2,926 total
  • Award
    QuidelOrtho Corp$QDEL

    Restricted Stock Units (Premium)

    2025-05-29+878→ 878 total
  • Award
    QuidelOrtho Corp$QDEL

    Restricted Stock Units (Equity Grant)

    2025-05-29+6,829→ 6,829 total
  • Award
    QuidelOrtho Corp$QDEL

    Common Stock

    2025-05-22+4,929→ 34,066 total
  • Exercise/Conversion
    QuidelOrtho Corp$QDEL

    Restricted Stock Units (Equity Grant)

    2025-05-22−4,929→ 0 total
  • Award
    Evoke Pharma Inc$EVOK

    Stock Option (Right to Buy)

    2025-05-21+1,187→ 8,207 total
  • Exercise/Conversion
    QuidelOrtho Corp$QDEL

    Restricted Stock Units (Converted)

    2025-05-18−512→ 0 total
  • Award
    QuidelOrtho Corp$QDEL

    Common Stock

    2025-05-18+153→ 29,137 total
  • Award
    QuidelOrtho Corp$QDEL

    Common Stock

    2025-05-18+512→ 28,984 total
  • Exercise/Conversion
    QuidelOrtho Corp$QDEL

    Restricted Stock Units (Premium )

    2025-05-18−153→ 0 total
  • Award
    Personalis, Inc.$PSNL

    Stock Option (right to buy)

    2025-05-16+50,000→ 50,000 total
  • Award
    Evoke Pharma Inc$EVOK

    Stock Option (Right to Buy)

    2025-01-28+5,833→ 5,833 total
  • Exercise/Conversion
    QuidelOrtho Corp$QDEL

    Non-Qualified Stock Option

    2024-07-19−3,333→ 0 total
  • Exercise/Conversion
    QuidelOrtho Corp$QDEL

    Common Stock

    2024-07-19$27.91/sh+3,333→ 28,472 total
  • Exercise/Conversion
    QuidelOrtho Corp$QDEL

    Restricted Stock Units (Equity Grant)

    2024-05-24−2,416→ 0 total
  • Award
    QuidelOrtho Corp$QDEL

    Common Stock

    2024-05-24+2,416→ 25,139 total
  • Award
    Evoke Pharma Inc$EVOK

    Stock Option (Right to Buy)

    2024-05-22+14,250→ 14,250 total
  • Award
    QuidelOrtho Corp$QDEL

    Restricted Stock Units (Equity Grant)

    2024-05-22+4,929→ 4,929 total
  • Award
    QuidelOrtho Corp$QDEL

    Restricted Stock Units (Premium)

    2024-05-22+633→ 633 total
  • Award
    QuidelOrtho Corp$QDEL

    Restricted Stock Units (Converted)

    2024-05-22+2,112→ 2,112 total
  • Award
    Personalis, Inc.$PSNL

    Stock Option (right to buy)

    2024-05-17+50,000→ 50,000 total
  • Award
    QuidelOrtho Corp$QDEL

    Common Stock

    2024-05-12+98→ 22,723 total
  • Exercise/Conversion
    QuidelOrtho Corp$QDEL

    Restricted Stock Units (Premium)

    2024-05-12−98→ 0 total
  • Exercise/Conversion
    QuidelOrtho Corp$QDEL

    Restricted Stock Units (Converted)

    2024-05-12−328→ 0 total
  • Award
    QuidelOrtho Corp$QDEL

    Common Stock

    2024-05-12+328→ 22,625 total
  • Award
    Personalis, Inc.$PSNL

    Stock Option (Right to Buy)

    2023-06-13+80,000→ 80,000 total
  • Exercise/Conversion
    QuidelOrtho Corp$QDEL

    Restricted Stock Units (Equity Grant)

    2023-06-06−2,248→ 0 total
  • Award
    QuidelOrtho Corp$QDEL

    Common Stock

    2023-06-06+2,248→ 22,297 total
  • Award
    QuidelOrtho Corp$QDEL

    Restricted Stock Units (Equity Grant)

    2023-05-24+2,416→ 2,416 total
  • Award
    QuidelOrtho Corp$QDEL

    Restricted Stock Units (Premium)

    2023-05-24+293→ 293 total
  • Award
    QuidelOrtho Corp$QDEL

    Restricted Stock Units (Converted)

    2023-05-24+978→ 978 total
  • Award
    QuidelOrtho Corp$QDEL

    Common Stock

    2023-05-14+1,050→ 19,734 total
  • Exercise/Conversion
    QuidelOrtho Corp$QDEL

    Restricted Stock Units (Premium)

    2023-05-14−315→ 0 total
  • Exercise/Conversion
    QuidelOrtho Corp$QDEL

    Restricted Stock Units (Converted)

    2023-05-14−1,050→ 0 total
  • Award
    QuidelOrtho Corp$QDEL

    Common Stock

    2023-05-14+315→ 20,049 total
  • Award
    Evoke Pharma Inc$EVOK

    Stock Option (Right to Buy)

    2023-05-10+14,250→ 14,250 total
  • Award
    QuidelOrtho Corp$QDEL

    Restricted Stock Units (Equity Grant)

    2022-06-06+2,248→ 2,248 total
  • Award
    QuidelOrtho Corp$QDEL

    Restricted Stock Units (Converted)

    2022-06-06+910→ 910 total
  • Award
    QuidelOrtho Corp$QDEL

    Restricted Stock Units (Premium)

    2022-06-06+273→ 273 total
  • Disposition to Issuer
    QUIDEL CORP /DE/

    Restricted Stock Units

    2022-05-27−98→ 0 total
  • Disposition to Issuer
    QUIDEL CORP /DE/

    Non-Qualified Stock Options

    2022-05-27−7,021→ 0 total
  • Disposition to Issuer
    QUIDEL CORP /DE/

    Restricted Stock Units

    2022-05-27−1,050→ 0 total
  • Award
    QuidelOrtho Corp$QDEL

    Restricted Stock Units

    2022-05-27+1,050→ 1,050 total
  • Award
    QuidelOrtho Corp$QDEL

    Non-Qualified Stock Options

    2022-05-27+7,021→ 7,021 total
  • Disposition to Issuer
    QUIDEL CORP /DE/

    Restricted Stock Units

    2022-05-27−328→ 0 total

Companies

5

Recent Filings

10

Address

C/O EVOKE PHARMA, INC. 12555 HIGH BLUFF DRIVE, SUITE 385

SAN DIEGO, CA, 92130

View on SEC.gov